Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
Share This

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Latest Mizuho News

Mizuho Financial Group launches strategic technology and operations center in Pune

Mizuho Financial Group launches strategic technology and operations center in Pune

May 21, 2026
A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

A lot of concern around consumer spending ahead of retail earnings, says Mizuho’s Bellinger

May 19, 2026
Why biotechnology stocks have more room to run

Why biotechnology stocks have more room to run

May 12, 2026

Mizuho news from around the globe

back-to-top-blue